We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » HGH Monograph Proves Follow-On Viability, GPhA Says
The U.S. Pharmacopeia’s (USP) new human growth hormone (HGH) monograph proves the science is sound for follow-on biologics and that such products can be accurately characterized, contends the Generic Pharmaceutical Association (GPhA).